Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial)

OBJECTIVES: Balloon pulmonary angioplasty (BPA) and medical therapy, such as soluble guanylate cyclase stimulators, are recommended treatments for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for pulmonary endarterectomy (PEA). However, monotherapy with BPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimokawahara, Hiroto, Inami, Takumi, Kubota, Kayoko, Taniguchi, Yu, Hashimoto, Hiroya, Saito, Akiko M, Sekimizu, Masahiro, Matsubara, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335556/
https://www.ncbi.nlm.nih.gov/pubmed/37407055
http://dx.doi.org/10.1136/bmjopen-2023-072241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335556/
https://www.ncbi.nlm.nih.gov/pubmed/37407055
http://dx.doi.org/10.1136/bmjopen-2023-072241

Ejemplares similares